TrialHuman vaccines & immunotherapeutics2016

Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes.

Mauricio Hernández-Ávila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.